Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App

Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE406A01037 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Dec 30, 16:01
1190.05 -8.95 (-0.75%)
Volume
AVERAGE VOLUME
5-Day
8,009
10-Day
33,527
30-Day
20,995
7,890
  • Prev. Close

    1199.00

  • Open Price

    1190.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Dec 30, 15:59
1186.30 -13.80 (-1.15%)
Volume
AVERAGE VOLUME
5-Day
609,227
10-Day
684,963
30-Day
756,946
1,058,434
  • Prev. Close

    1200.10

  • Open Price

    1202.00

  • Bid Price (Qty.)

    1186.30 (244)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Key Financial Ratios of Aurobindo Pharma (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22 Mar 21  
Per Share Ratios  
Basic EPS (Rs.) 29.97 33.35 21.00 24.83 53.13  
Diluted EPS (Rs.) 29.97 33.35 21.00 24.83 53.13  
Cash EPS (Rs.) 35.19 37.70 28.43 31.92 61.46  
Book Value [ExclRevalReserve]/Share (Rs.) 353.55 336.62 305.75 292.15 271.80  
Book Value [InclRevalReserve]/Share (Rs.) 353.55 336.62 305.75 292.15 271.80  
Dividend / Share(Rs.) 0.00 4.50 3.00 9.00 4.00  
Revenue from Operations/Share (Rs.) 188.25 181.70 218.34 192.65 270.07  
PBDIT/Share (Rs.) 49.68 48.47 36.95 36.60 80.38  
PBIT/Share (Rs.) 44.57 44.13 29.52 29.51 72.05  
PBT/Share (Rs.) 40.61 41.01 27.55 27.95 71.57  
Net Profit/Share (Rs.) 30.08 33.35 21.00 24.83 53.13  
Profitability Ratios  
PBDIT Margin (%) 26.39 26.67 16.92 18.99 29.76  
PBIT Margin (%) 23.67 24.28 13.51 15.31 26.67  
PBT Margin (%) 21.57 22.57 12.61 14.50 26.49  
Net Profit Margin (%) 15.97 18.35 9.61 12.88 19.67  
Return on Networth / Equity (%) 8.50 9.90 6.86 8.49 19.54  
Return on Capital Employed (%) 12.27 12.98 9.47 9.92 25.69  
Return on Assets (%) 6.34 7.76 4.93 6.73 13.42  
Total Debt/Equity (X) 0.23 0.14 0.23 0.11 0.25  
Asset Turnover Ratio (%) 0.42 0.43 0.55 0.50 0.74  
Liquidity Ratios  
Current Ratio (X) 1.20 1.38 1.46 2.35 1.83  
Quick Ratio (X) 0.83 0.93 0.84 1.55 1.12  
Inventory Turnover Ratio (X) 4.63 1.77 1.94 1.41 1.58  
Dividend Payout Ratio (NP) (%) 0.00 13.49 35.71 18.12 7.52  
Dividend Payout Ratio (CP) (%) 0.00 11.93 26.38 14.10 6.50  
Earnings Retention Ratio (%) 0.00 86.51 64.29 81.88 92.48  
Cash Earnings Retention Ratio (%) 0.00 88.07 73.62 85.90 93.50  
Valuation Ratios  
Enterprise Value (Cr.) 71,682.11 66,554.38 34,360.05 40,961.62 55,216.93  
EV/Net Operating Revenue (X) 6.56 6.25 2.69 3.63 3.49  
EV/EBITDA (X) 24.84 23.43 15.87 19.10 11.72  
MarketCap/Net Operating Revenue (X) 6.16 6.00 2.37 3.47 3.26  
Retention Ratios (%) 0.00 86.50 64.28 81.87 92.47  
Price/BV (X) 3.28 3.24 1.69 2.29 3.24  
Price/Net Operating Revenue 6.16 6.00 2.37 3.47 3.26  
Earnings Yield 0.03 0.03 0.04 0.04 0.06  
Source : Dion Global Solutions Limited

Results of Aurobindo Pharm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347